BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25477897)

  • 21. Hematological malignancies: role of miRNAs and their in silico aspects.
    Omer A; Yadav NK; Singh P; Singh RK
    Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia.
    Li G; Gao Y; Li K; Lin A; Jiang Z
    Oncol Lett; 2020 Aug; 20(2):1824-1834. PubMed ID: 32724426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs in myeloid malignancies.
    Gordon JE; Wong JJ; Rasko JE
    Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs: pivotal regulators in acute myeloid leukemia.
    Li M; Cui X; Guan H
    Ann Hematol; 2020 Mar; 99(3):399-412. PubMed ID: 31932900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
    Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.
    Zhang C; Bai G; Zhu W; Bai D; Bi G
    Med Sci Monit; 2017 Oct; 23():4705-4714. PubMed ID: 28965123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.
    Georgantas RW; Hildreth R; Morisot S; Alder J; Liu CG; Heimfeld S; Calin GA; Croce CM; Civin CI
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2750-5. PubMed ID: 17293455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stromal cells in myeloid malignancies.
    Schroeder T; Geyh S; Germing U; Haas R
    Blood Res; 2016 Dec; 51(4):225-232. PubMed ID: 28090484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interplay between critical transcription factors and microRNAs in the control of normal and malignant myelopoiesis.
    Stavast CJ; Leenen PJM; Erkeland SJ
    Cancer Lett; 2018 Jul; 427():28-37. PubMed ID: 29673909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
    Liu Y; Cheng Z; Pang Y; Cui L; Qian T; Quan L; Zhao H; Shi J; Ke X; Fu L
    J Hematol Oncol; 2019 May; 12(1):51. PubMed ID: 31126316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. microRNAs: Key Players in Hematopoiesis.
    Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
    Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor.
    Lin XC; Xu Y; Sun GP; Wen JL; Li N; Zhang YM; Yang ZG; Zhang HT; Dai Y
    Int J Oncol; 2016 Jun; 48(6):2367-80. PubMed ID: 27082628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.